These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2439571)

  • 1. The interaction of interferon with the immune response.
    Morris A; Cooley M; Blackman M
    J Hepatol; 1986; 3 Suppl 2():S161-9. PubMed ID: 2439571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon and major histocompatibility complex genes: a model to analyse eukaryotic gene regulation?
    Rosa FM; Cochet MM; Fellous M
    Interferon; 1986; 7():47-87. PubMed ID: 2434435
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological functions of macrophages and their regulation by interferons.
    Virelizier JL; Arenzana-Seisdedos F
    Med Biol; 1985; 63(4):149-59. PubMed ID: 2419711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoenzyme analysis of the change in the expression of class II antigens of the major histocompatibility complex under the influence of interferon preparations].
    Kremlev SG; Medunitsyn NV
    Biull Eksp Biol Med; 1989 Nov; 108(11):577-80. PubMed ID: 2517405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the relevance of the various immunomodulatory effects of interferons?
    Morris A
    Ann Inst Pasteur Immunol (1985); 1985; 136D(1):79-81. PubMed ID: 2415043
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons, interferon-like cytokines, and their receptors.
    Pestka S; Krause CD; Walter MR
    Immunol Rev; 2004 Dec; 202():8-32. PubMed ID: 15546383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1982 Kurt Paucker Memorial Lecture: the need to understand.
    De Maeyer E
    J Interferon Res; 1983; 3(1):1-10. PubMed ID: 6188790
    [No Abstract]   [Full Text] [Related]  

  • 11. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding.
    Routes JM; Li H; Bayley ST; Ryan S; Klemm DJ
    J Immunol; 1996 Feb; 156(3):1055-61. PubMed ID: 8557979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons.
    Morris AG
    Immunol Suppl; 1988; 1():43-5. PubMed ID: 2454889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
    Reiter Z
    J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of immune lysis of tumor cells by interferon.
    Ng AK; Imai K; Pellegrino MA; Vitiello A; Indiveri F; Wilson BS; Ferrone S
    Biomembranes; 1983; 11():313-39. PubMed ID: 6187384
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrovirus-mediated gene transfer of the human gamma-IFN gene: a therapy for cancer.
    Howard B; Burrascano M; McCallister T; Chong K; Gangavalli R; Severinsson L; Jolly DJ; Darrow T; Vervaert C; Abdel-Wahab Z
    Ann N Y Acad Sci; 1994 May; 716():167-87. PubMed ID: 8024193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic effects of interferon.
    Knop J
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):72S-74S. PubMed ID: 1701812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity of gamma interferon.
    Dianzani F; Antonelli G; Capobianchi MR
    Ann Ist Super Sanita; 1990; 26(3-4):255-61. PubMed ID: 2128676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-modulating properties of interferons.
    De Maeyer E; De Maeyer-Guignard J
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):77-90. PubMed ID: 6183698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.